Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 1953, Safeguard Scientifics is based in Wayne, Pennsylvania. The organization has historically focused on building and investing in technology and healthcare companies. Over the decades, it has played a significant role in supporting early-stage startups and established businesses, emphasizing innovation and growth potential within these sectors.
As of 2023, Safeguard is not actively pursuing new investments. Instead, it is concentrating on portfolio monetization and maximizing shareholder returns. The firm has undergone significant changes, including a strategic shift towards reducing operating costs and allowing remaining portfolio companies to exit over a two-year period. This transition marks a departure from its previous role as a venture capital investor.
Safeguard's historical commitment to innovation has led to a diverse portfolio, primarily in the healthcare and technology sectors. The firm has been instrumental in providing capital and strategic support to its portfolio companies, helping them navigate growth challenges and capitalize on market opportunities.
Safeguard Scientifics has historically invested in technology and healthcare sectors, providing capital and support to companies at various stages of development, including pre-seed, seed, Series A, Series B, Series C, and growth equity. Their investment strategy emphasizes innovation and growth potential, particularly in technology-driven businesses.
While the organization is currently focused on portfolio monetization and shareholder returns, its historical investment thesis centered on nurturing technology-driven businesses. Safeguard has provided not only capital but also strategic support and expertise to help portfolio companies navigate challenges and seize market opportunities.
Although Safeguard is not currently active in new investments, its past focus on technology and healthcare remains relevant for understanding its historical impact on these sectors. Founders should note that the firm is now primarily concerned with maximizing value for existing shareholders.
Safeguard Scientifics has a diverse portfolio that includes several notable companies in the healthcare and technology sectors. The following companies are part of their historical investments:
These companies reflect Safeguard's commitment to investing in technology and healthcare innovation, although the firm is currently not pursuing new investments.
John W. McGowan - Chief Executive Officer. He has led the organization through various strategic transitions and has been involved in discussions regarding the firm's future direction.
Michael J. McGowan - Chief Financial Officer. He oversees financial operations and has played a key role in managing the firm's financial strategy during its transition.
David A. B. Heller - Chief Operating Officer. He is responsible for the operational aspects of the firm and has been involved in the management of portfolio companies.
Kristin M. McCarthy - Chief Marketing Officer. She has contributed to the firm's marketing strategies and communications, particularly during its strategic shift.
For pitches, interested parties can visit safeguard.com. However, it is crucial to recognize that Safeguard Scientifics is currently not pursuing new investments. The firm is focused on portfolio monetization and maximizing shareholder returns, which means that founders should not expect a response regarding new funding opportunities.
In 2023, Safeguard Scientifics announced a strategic plan to pursue alternatives for maximizing shareholder value. This included a focus on portfolio monetization and returning excess cash to shareholders. The firm also communicated its intention to reduce operating costs and allow remaining portfolio companies to exit over a two-year period.
Additionally, Safeguard's Board of Directors approved a plan to voluntarily terminate the registration of its common stock with the SEC and delist from Nasdaq, marking a significant shift in the firm's operational strategy.
What are Safeguard Scientifics' investment criteria?
Safeguard Scientifics historically focused on technology and healthcare sectors, investing in companies at various stages, including pre-seed, seed, Series A, Series B, Series C, and growth equity. Their emphasis was on innovation and growth potential.
How can I pitch to Safeguard Scientifics?
Interested parties can visit safeguard.com for pitch submissions. However, it is important to note that Safeguard is currently not active in new investments.
What makes Safeguard Scientifics different from other investors?
Historically, Safeguard provided not only capital but also strategic support and expertise to its portfolio companies, helping them navigate growth challenges. Currently, the firm is focused on maximizing value for existing shareholders through portfolio monetization.
What is the geographic focus of Safeguard Scientifics?
Safeguard has historically focused on investments within the United States, particularly in Pennsylvania, where it is based.
What is the current status of Safeguard Scientifics?
As of 2023, Safeguard Scientifics is not actively pursuing new investments and is instead concentrating on portfolio monetization and shareholder returns. The firm is undergoing a strategic transition to reduce operating costs and allow remaining portfolio companies to exit.
What types of companies does Safeguard typically invest in?
Safeguard has historically invested in technology-driven businesses, particularly in the healthcare and technology sectors. Their portfolio includes companies that reflect this focus.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.